Lipases and HDL metabolism

Trends in Endocrinology and Metabolism

Volumn 13, Issue 4, 2002, Pages 174-178

  Jin, Weijun ^a   Marchadier, Dawn ^a   Rader, Daniel J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL LIPASE; LIPG PROTEIN, HUMAN; LIPOPROTEIN LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE A;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME RELEASE; GENE OVEREXPRESSION; LIPID METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; REMISSION; REVIEW; VASCULAR DISEASE; ADIPOCYTE; ANIMAL; ARTERIOSCLEROSIS; BLOOD; ENZYMOLOGY; GENETICS; HUMAN; LIVER; METABOLISM;

ADIPOCYTES; ANIMALS; ARTERIOSCLEROSIS; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LIVER; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPASES A;

EID: 0036582556     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00589-1     Document Type: Review

References (83)

1. Reichl, D. and Miller, N.E. (1989) Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9, 785-797
2. Barter, P.J. and Rye, K. (1996) Molecular mechanisms of reverse cholesterol transport. Curr. Opin. Lipidol. 7, 82-87
3. Berliner, J.A. et al. (1995) Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91, 2488-2496
4. Cockerill, G. et al. (1995) High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15, 1987-1994
5. Baker, P.W. et al. (1999) Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J. Lipid Res. 40, 345-353
6. Griffin, J.H. et al. (2001) Plasma lipoproteins, hemostasis and thrombosis. Thromb. Haemost. 86, 386-394
7. Yuhanna, I.S. et al. (2001) High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 7, 853-857
8. Rader, D.J. and Ikewaki, K. (1996) Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr. Opin. Lipidol. 7, 117-123
9. Tall, A.R. (1990) Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86, 379-384
10. Goldberg, I.J. (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37, 693-707
11. Zechner, R. (1997) The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr. Opin. Lipidol. 8, 77-88
12. Clee, S.M. et al. (1997) Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice: modulation by cholesteryl ester transfer protein and dietary status. J. Lipid Res. 38, 2079-2089
13. Coleman, T. et al. (1995) COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J. Biol. Chem. 270, 12518-12525
14. Weinstock, P.H. et al. (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. J. Clin. Invest. 96, 2555-2568
15. Levak-Frank, S. et al. (1999) Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. Proc. Natl. Acad. Sci. U. S. A. 96, 3165-3170
16. Levak-Frank, S. et al. (1997) Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma. J. Biol. Chem. 272, 17182-17190
17. Santamarina-Fojo, S. (1992) Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein C-II. Curr. Opin. Lipidol. 3, 186-195
18. Hokanson, J.E. (1997) Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int. J. Clin. Lab. Res. 27, 24-34
19. Blades, B. et al. (1993) Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb. 13, 1227-1235
20. Humphries, S.E. et al. (1998) Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler. Thromb. Vasc. Biol. 18, 526-534
21. Shimada, M. et al. (1996) Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc. Natl. Acad. Sci. U. S. A. 93, 7242-7246
22. Yagyu, H. et al. (1999) Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J. Lipid Res. 40, 1677-1685
23. Fan, J. et al. (2001) Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 276, 40071-40079
24. Tsutsumi, K. et al. (1993) The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J. Clin. Invest. 92, 411-417
25. Babaev, V.R. et al. (1999) Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 103, 1697-1705
26. Bensadoun, A. and Berryman, D.E. (1996) Genetics and molecular biology of hepatic lipase. Curr. Opin. Lipidol. 7, 77-81
27. Santamarina-Fojo, S. et al. (1998) The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin. Lipidol. 9, 211-219
28. Connelly, P.W. (1999) The role of hepatic lipase in lipoprotein metabolism. Clin. Chim. Acta 286, 243-255
29. Rye, K.A. et al. (1999) Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145, 227-238
30. Mowri, H.O. et al. (1996) Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arterioscler. Thromb. Vasc. Biol. 16, 755-762
31. Weng, W. et al. (1999) ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice. J. Lipid Res. 40, 1064-1070
32. Boisfer, E. et al. (1999) Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis. J. Biol. Chem. 274, 11564-11572
33. Busch, S.J. et al. (1994) Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269, 16376-16382
34. Dichek, H.L. et al. (1998) Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. Biol. Chem. 273, 1896-1903
35. Braschi, S. et al. (1998) Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse. Biochim. Biophys. Acta 1392, 276-290
36. Fan, J. et al. (1994) Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 91, 8724-8728
37. Barbagallo, C.M. et al. (1999) Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler. Thromb. Vasc. Biol. 19, 625-632
38. Applebaum-Bowden, D. et al. (1996) Hepatic lipase gene therapy in hepatic-lipase deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium. J. Clin. Invest. 97, 799-805
39. Dugi, K.A. et al. (1997) Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J. Lipid Res. 38, 1822-1832
40. Amar, M.J. et al. (1998) Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice. J. Lipid Res. 39, 2436-2442
41. Dugi, K.A. et al. (2000) In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL. Arterioscler. Thromb. Vasc. Biol. 20, 793-800
42. Homanics, G.E. et al. (1995) Mild dyslipidemia in Mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270, 2974-2980
43. Connelly, P.W. et al. (1990) Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 10, 40-48
44. Hegele, R. et al. (1993) Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13, 720-728
45. Cohen, J.C. et al. (1994) Variation at the hepatic lipase and apolopoprotein AI/CII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94, 2377-2384
46. Guerra, R. et al. (1997) A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density liporotein cholesterol. Proc. Natl. Acad. Sci. U. S. A. 94, 4532-4537
47. De, O. et al. (1999) Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J. Lipid Res. 40, 1211-1221
48. Hegele, R.A. et al. (1999) Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 146, 153-160
49. Mezdour, H. et al. (1997) Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J. Biol. Chem. 272, 13570-13575
50. Descamps, V. et al. (1994) Erythropoientin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum. Gene Ther. 5, 979-985
51. Katzel, L.I. et al. (1992) Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler. Thromb. 12, 814-823
52. Dugi, K.A. et al. (2001) Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 104, 3057-3062
53. Zambon, A. et al. (2001) Hepatic lipase as a focal point for the development and treatment of coronary artery disease. J. Investig. Med. 49, 112-118
54. Jaye, M. et al. (1999) A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21, 424-428
55. Hirata, K. et al. (1999) Cloning of a unique lipase from endothelial cells extends the lipase gene family. J. Biol. Chem. 274, 14170-14175
56. Rader, D.J. and Jaye, M. (2000) Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin. Lipidol. 11, 141-147
57. Tischfield, J.A. (1997) A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272, 17247-17250
58. Pruzanski, W. et al. (1988) Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J. Rheumatol. 15, 1351-1355
59. Lin, M.K. et al. (1996) Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J. Rheumatol. 23, 1162-1166
60. Pruzanski, W. et al. (1998) Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. J. Lipid Res. 39, 2150-2160
61. de beer, F.C. et al. (1997) Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism. J. Lipid Res. 38, 2232-2239
62. Tietge, U.J. et al. (2000) Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J. Biol. Chem. 275, 10077-10084
63. de beer, F. C. et al. (2000) HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J. Lipid Res. 41, 1849-1857
64. Subbaiah, P.V. et al. (1994) Substrate and positional specificities of human and mouse lecithin-cholesterol acyltransferases. Studies with wild type recombinant and chimeric enzymes expressed in vitro. Biochim. Biophys. Acta 1215, 150-156
65. Santamarina-Fojo, S. et al. (2000) Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 11, 267-275
66. Vaisman, B.L. et al. (1995) Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270, 12269-12275
67. Francone, O.L. et al. (1997) Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. J. Lipid Res. 38, 813-822
68. Hoeg, J.M. et al. (1996) Lecithin:cholesterol acyltransferase overexpression generates hyperalphalipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 271, 4396-4402
69. Seguret-Mace, S. et al. (1996) Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene. Circulation 94, 2177-2184
70. Brousseau, M.E. et al. (1996) Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. J. Clin. Invest. 97, 1844-1851
71. Brousseau, M.E. et al. (1997) Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner. J. Lipid Res. 38, 2537-2547
72. Ng, D.S. et al. (1997) Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and upregulation of scavenger receptor class B type I. J. Biol. Chem. 272, 15777-15781
73. Lambert, G. et al. (2001) Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J. Biol. Chem. 276, 15090-15098
74. Kuivenhoven, J.A. et al. (1997) The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38, 191-205
75. Rader, D.J. et al. (1994) Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin:cholesterol acyltransferase deficiency and fish-eye disease. J. Clin. Invest. 93, 321-330
76. Mowri, H.O. et al. (1994) High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin:cholesterol acyltransferase. J. Lipid Res. 35, 291-300
77. Williams, P.T. et al. (1990) Associations of lecithin:cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men. Atherosclerosis 82, 53-58
78. Hoeg, J.M. et al. (1996) Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 93, 11448-11453
79. Brousseau, M.E. et al. (2000) LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Arterioscler Thromb. Vasc. Biol. 20, 450-458
80. Berard, A.M. et al. (1997) High plasma HDL concentration associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat. Med. 3, 744-749
81. Mehlum, A. et al. (2000) Overexpression of human lecithin: cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis. APMIS 108, 336-342
82. Foger, B. et al. (1999) Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274, 36912-36920
83. Furbee, J.W., Jr et al. (2002) Lecithin:cholesterol acyltransferase (LCAT) deficiency increases atherosclerosis in the low density lipoprotein receptor (LDLr) or apolipoprotein E (apoE) knockout mice. J. Biol. Chem. 277, 3511-3519